Tissue plasminogen activator levels change with plasma fibrinogen concentrations during pregnancy

被引:52
作者
Choi, JW [1 ]
Pai, SH [1 ]
机构
[1] Inha Univ Hosp, Coll Med, Dept Clin Pathol, Jung Gu, Inchon 400103, South Korea
关键词
coagulation factors; fibrinogen; pregnancy; tissue plasminogen activator;
D O I
10.1007/s00277-002-0549-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To investigate the relationship between coagulation activities and the fibrinolytic system during normal pregnancy, we measured the plasma concentrations of coagulation factors, antithrombin III (AT III), D-dimer, tissue plasminogen activator (tPA), total protein S (TPS), and plasminogen activator inhibitor type 1 (PAI-1) in 436 apparently healthy pregnant, postpartum, and nonpregnant women. There were no significant changes in AT III, TPS, and factor XI concentrations during pregnancy and puerperium. However, factor VII, VIII, IX, and XII activities increased gradually as pregnancy progressed, reached maximum values in the third trimester, and returned to nonpregnant levels by 5-8 weeks postpartum. Plasma D-dimer levels in the third trimester of pregnancy were 1.23+/-0.42 pg/ml, significantly higher than for the first trimester (0.34+/-0.16 pg/ml, P<0.01). The tPA antigen levels averaged 1.8-fold higher in the late third trimester than in the first trimester; the plasma fibrinogen concentrations averaged 1.6-fold higher in the late third trimester than in the first trimester. Compared to the peak values during pregnancy, tPA levels averaged 39.8% lower and plasma fibrinogen concentrations averaged 40.0% lower at 5-8 weeks postpartum. The tPA levels correlated strongly with the plasma fibrinogen concentrations (r=0.52, P<0.01). In short, this study shows that tPA levels change in parallel with plasma fibrinogen concentrations during and after normal pregnancy.
引用
收藏
页码:611 / 615
页数:5
相关论文
共 50 条
[31]   Plasmin degradation of the alpha chain of fibrinogen/fibrin: improved activation constant and activity determination in assays for tissue plasminogen activator [J].
Garces, Tatiana M. P. ;
Alfonso Quijano, P. ;
Luis Fernando Arbelaez, R. .
IATREIA, 2013, 26 (03) :291-301
[32]   Acute Ischemic Stroke in Term Pregnancy Treated with Recombinant Tissue Plasminogen Activator [J].
Aaron, Sanjith ;
Mannam, Pavitra Ratna ;
Shaikh, Atif ;
Mani, Arun Mathai ;
Bal, Deepti ;
Pandian, Jeyaraj Durai .
CASE REPORTS IN NEUROLOGY, 2020, 12 (SUPPL 1) :4-8
[33]   Soluble urokinase plasminogen activator receptor (suPAR) levels in healthy pregnancy and preeclampsia [J].
Toldi, Gergely ;
Biro, Edina ;
Szalay, Balazs ;
Stenczer, Balazs ;
Molvarec, Attila ;
Rigo, Janos, Jr. ;
Vasarhelyi, Barna ;
Beko, Gabriella .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 (11) :1873-1876
[34]   EFFECT OF DEXTRAN ON PLASMA TISSUE-PLASMINOGEN ACTIVATOR (T-PA) AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) DURING SURGERY [J].
ERIKSSON, M ;
SALDEEN, T .
ACTA ANAESTHESIOLOGICA SCANDINAVICA, 1995, 39 (02) :163-166
[35]   Adiponectin is an independent predictor of tissue plasminogen activator levels in patients under haemodialysis [J].
Faria, Maria do Sameiro ;
Ribeiro, Sandra ;
Nascimento, Henrique ;
Rocha-Pereira, Petronila ;
Miranda, Vasco ;
Mendonca, Denisa ;
Quintanilha, Alexandre ;
Costa, Elisio ;
Belo, Luis ;
Santos-Silva, Alice .
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2012, 46 (06) :461-465
[36]   Use of Intracameral Tissue Plasminogen Activator During Uveitic Cataract Surgery [J].
Hu, Wen F. ;
Etheridge, Tyler ;
Larochelle, Marissa B. .
OCULAR IMMUNOLOGY AND INFLAMMATION, 2024, 32 (05) :673-677
[37]   Progressive and transient expression of tissue plasminogen activator during fetal development [J].
Levin, EG ;
Banka, CL ;
Parry, GCN .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (06) :1668-1674
[38]   Dynamic changes in plasma tissue plasminogen activator, plasminogen activator inhibitor-1 and beta-thromboglobulin content in ischemic stroke [J].
Zhuang, Ping ;
Wo, Da ;
Xu, Zeng-guang ;
Wei, Wei ;
Mao, Hui-ming .
JOURNAL OF CLINICAL NEUROSCIENCE, 2015, 22 (07) :1123-1127
[39]   STIMULATING EFFECT ON TISSUE-TYPE PLASMINOGEN-ACTIVATOR - A NEW AND SENSITIVE INDICATOR OF DENATURED FIBRINOGEN [J].
HADDELAND, U ;
BENNICK, A ;
BROSSTAD, F .
THROMBOSIS RESEARCH, 1995, 77 (04) :329-336
[40]   Progression of plasminogen activator inhibitor-1 and fibrinogen levels in relation to incident type 2 diabetes [J].
Festa, A ;
Williams, K ;
Tracy, RP ;
Wagenknecht, LE ;
Haffner, SM .
CIRCULATION, 2006, 113 (14) :1753-1759